PCSK9 and systemic lupus erythematosus: Earlier, we have reported that PCSK9-levels are raised among patients with high disease activity in systemic lupus erythematosus (SLE) and that OxLDL induced PCSK9 in dendritic cells (DC), effects which were significantly stronger in DCs from SLE patients than from controls [17].